167 related items for PubMed ID: 3615749
1. Use of the dexamethasone suppression test with DSM-III criteria in psychiatrically hospitalized adolescents.
Evans DL, Nemeroff CB, Haggerty JJ, Pedersen CA.
Psychoneuroendocrinology; 1987; 12(3):203-9. PubMed ID: 3615749
[Abstract] [Full Text] [Related]
2. Hypothalamic-pituitary-adrenal-axis hyperactivity in bulimia.
Hudson JI, Pope HG, Jonas JM, Laffer PS, Hudson MS, Melby JC.
Psychiatry Res; 1983 Feb; 8(2):111-7. PubMed ID: 6574529
[Abstract] [Full Text] [Related]
3. Plasma corticosterone and cortisol following dexamethasone in psychiatric patients.
Arana GW, Wilens TE, Baldessarini RJ.
Psychoneuroendocrinology; 1985 Feb; 10(1):49-60. PubMed ID: 4001277
[Abstract] [Full Text] [Related]
4. The dexamethasone suppression test in depressed and non-depressed geriatric medical inpatients.
Magni G, Schifano F, De Leo D, De Dominicis MG, Garbin A, Zangaglia O.
Acta Psychiatr Scand; 1986 May; 73(5):511-4. PubMed ID: 3751656
[Abstract] [Full Text] [Related]
5. The dexamethasone suppression test in prepubertal depressed children.
Weller EB, Weller RA, Fristad MA, Preskorn SH, Teare M.
J Clin Psychiatry; 1985 Dec; 46(12):511-3. PubMed ID: 4066616
[Abstract] [Full Text] [Related]
6. Age and the dexamethasone suppression test: results from a broad unselected patient population.
Keitner GI, Ryan CE, Kohn R, Miller IW, Norman WH, Brown WA.
Psychiatry Res; 1992 Oct; 44(1):9-20. PubMed ID: 1461951
[Abstract] [Full Text] [Related]
7. The clinical use of the dexamethasone suppression test in DSM-III affective disorders: correlation with the severe depressive subtypes of melancholia and psychosis.
Evans DL, Nemeroff CB.
J Psychiatr Res; 1987 Oct; 21(2):185-94. PubMed ID: 3585807
[Abstract] [Full Text] [Related]
8. Nonsuppression of cortisol in depression and immune function.
Syvälahti E, Eskola J, Ruuskanen O, Laine T.
Prog Neuropsychopharmacol Biol Psychiatry; 1985 Oct; 9(4):413-22. PubMed ID: 4070644
[Abstract] [Full Text] [Related]
9. The dexamethasone suppression test in adolescent psychiatric inpatients.
Targum SD, Capodanno AE.
Am J Psychiatry; 1983 May; 140(5):589-91. PubMed ID: 6846588
[Abstract] [Full Text] [Related]
10. The dexamethasone suppression test in the clinical setting.
Evans DL, Burnett GB, Nemeroff CB.
Am J Psychiatry; 1983 May; 140(5):586-9. PubMed ID: 6342422
[Abstract] [Full Text] [Related]
11. Neuroendocrine interrelationships in major depressive disorder.
Targum SD, Sullivan AC, Byrnes SM.
Am J Psychiatry; 1982 Mar; 139(3):282-6. PubMed ID: 6800269
[Abstract] [Full Text] [Related]
12. Comorbidity in the interpretation of dexamethasone suppression test results in children: a review and report.
Steingard R, Biederman J, Keenan K, Moore C.
Biol Psychiatry; 1990 Aug 01; 28(3):193-202. PubMed ID: 2198952
[Abstract] [Full Text] [Related]
13. Use of the dexamethasone suppression test in an inpatient setting: a replication and new findings.
Maes M, De Ruyter M, Suy E.
Psychoneuroendocrinology; 1989 Aug 01; 14(3):231-9. PubMed ID: 2756075
[Abstract] [Full Text] [Related]
14. Depression and dexamethasone suppression testing in children and adolescents.
Emslie GJ, Weinberg WA, Rush AJ, Weissenburger J, Parkin-Feigenbaum L.
J Child Neurol; 1987 Jan 01; 2(1):31-7. PubMed ID: 3624827
[Abstract] [Full Text] [Related]
15. Neuroendocrine aspects of primary endogenous depression. II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response.
Poland RE, Rubin RT, Lesser IM, Lane LA, Hart PJ.
Arch Gen Psychiatry; 1987 Sep 01; 44(9):790-5. PubMed ID: 3632252
[Abstract] [Full Text] [Related]
16. The dexamethasone suppression test in agoraphobia.
Peterson GA, Ballenger JC, Cox DP, Hucek A, Lydiard RB, Laraia MT, Trockman C.
J Clin Psychopharmacol; 1985 Apr 01; 5(2):100-2. PubMed ID: 3988966
[Abstract] [Full Text] [Related]
17. The dexamethasone suppression test in depressive, non-depressive and schizoaffective psychosis.
Coccaro EF, Prudic J, Rothpearl A, Nurnberg HG.
J Affect Disord; 1985 Sep 01; 9(2):107-13. PubMed ID: 2932482
[Abstract] [Full Text] [Related]
18. The influence of weight loss on the dexamethasone suppression test.
Yerevanian BI, Baciewicz GJ, Iker HP, Privitera MR.
Psychiatry Res; 1984 Jun 01; 12(2):155-60. PubMed ID: 6591220
[Abstract] [Full Text] [Related]
19. Cortisol and corticosterone response after syn-corticotropin in relationship to dexamethasone suppressibility of cortisol.
Gerken A, Holsboer F.
Psychoneuroendocrinology; 1986 Jun 01; 11(2):185-94. PubMed ID: 3018821
[Abstract] [Full Text] [Related]
20. Depression dexamethasone nonsuppression and negative symptoms in schizophrenia.
Addington D, Addington J.
Can J Psychiatry; 1990 Jun 01; 35(5):430-3. PubMed ID: 2372754
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
